<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND AIMS: Barrett's <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> is usually included in gastroesophageal (GE) junction <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in Japanese people </plain></SENT>
<SENT sid="1" pm="."><plain>No study on the pathogenesis of Barrett's <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> in comparison with GE junction <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> other than Barrett's <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> has been reported in Japan </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to evaluate the clinical and pathological characteristics and gastric acid secretion of Barrett's <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> and GE junction <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> other than Barrett's <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> in Japanese subjects </plain></SENT>
<SENT sid="3" pm="."><plain>MATERIAL AND METHODS: Twenty-three patients with Barrett's <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> and 23 patients with GE junction <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> other than Barrett's <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> were enrolled in this study </plain></SENT>
<SENT sid="4" pm="."><plain>We evaluated and compared them by assessing the Helicobactor pylori (HP) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> status and gastric acid secretion using the endoscopic gastrin test (EGT) </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: In the patients with Barrett's <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e>, no significant difference was found in the mean EGT value between HP-positive and -negative patients, but in the patients with GE junction <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> other than Barrett's <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e>, the mean EGT value in HP-positive patients was significantly lower than that in HP-negative patients </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: Two distinct types of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> of different origin may be mixed in GE junction <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>One is Barrett's <z:e sem="disease" ids="C0546837,C0014859" disease_type="Neoplastic Process" abbrv="">esophageal cancer</z:e> associated with high gastric acid secretion and reflux of gastric acid into the esophagus, the other is <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> resembling distal <z:hpo ids='HP_0012126'>gastric cancer</z:hpo> associated with gastric <z:mpath ids='MPATH_127'>atrophy</z:mpath> and low gastric acid secretion </plain></SENT>
</text></document>